Blog

Melvin LK Chua on the individualization of systemic therapies with radiotherapy in NPC at ESMO24

Photo from Melvin LK Chua/X

Sep 11, 2024, 13:57

Melvin LK Chua on the individualization of systemic therapies with radiotherapy in NPC at ESMO24

Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of Radiation Oncology at National Cancer Centre Singapore, shared a post on X:

”Thanks. Vivek Subbiah will be there!

Come join us as I share insights on individualisation of systemic therapies with radiotherapy in nasopharyngeal carcinoma along with Pierre Blanchard and Professor Brigette Ma from CUHK Medicine at ESMO24.”

Source: Melvin LK Chua/X

Brigette Ma cancer CUHK Medicine ESMO24 Melvin LK Chua nasopharyngeal carcinoma National Cancer Centre Singapore OncoDaily Oncology Pierre Blanchard radiotherapy Vivek Subbiah

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage